| Literature DB >> 24927959 |
Susan Hills1, Rebecca Martin, Anthony Marfin, Marc Fischer.
Abstract
Japanese encephalitis (JE) virus is the most common vaccine-preventable cause of encephalitis in Asia. Recent progress in the development and availability of improved JE vaccines has revitalized the prospects for JE control. There now are a number of safe and effective vaccines, two WHO prequalified vaccines available for pediatric use, at least one vaccine considered affordable for use in lower income countries, and a GAVI Alliance commitment to provide financial support to eligible countries for campaigns for children aged 9 months through 14 years. While challenges remain, this tremendous progress means there is a better opportunity than at any time in the past to prevent the substantial morbidity and mortality from this disease.Entities:
Keywords: Japanese encephalitis vaccine; epidemiology; prevention and control
Mesh:
Substances:
Year: 2014 PMID: 24927959 PMCID: PMC4594829 DOI: 10.1586/14787210.2014.929498
Source DB: PubMed Journal: Expert Rev Anti Infect Ther ISSN: 1478-7210 Impact factor: 5.091